Current Month 2011
Article Features
  Age Affects Short-Term Quality of Life After Breast Biopsy
Clinical Trial Finds Concurrent Therapy Not Necessary to Achieve High Pathological Remission in Breast Cancer
Compression Bandaging Comparable to Lymphatic Massage as Treatment for Lymphedema
Early Stages of Breast Cancer Could Soon Be Diagnosed From Blood Samples
Gene Sequencing Reveals Mutations Linked to Breast Cancer Treatment Resistance
High-Fat Diet During Puberty Speeds Up Breast Cancer Development
Largest Ever Study of Male Breast Cancer Treatment Shows More Mastectomy, Less Radiation Than in Female Disease
Linking Risk Factors and Disease Origins in Breast Cancer
Machines Learn to Detect Breast Cancer
Manipulation of a Protein Could Help Stop the Spread of Cancer Cells
Molecule Common in Some Cancers, Rheumatoid Arthritis, Leads to Potential Therapy for Both
Mutations of Immune System Found in Breast Cancer
Negative BRCA Testing May Not Always Imply Lowered Breast Cancer Risk
Nurse Navigators Help Cancer Patients Cope Early in Care
Obesity Found to be Major Risk Factor in Developing Basal-Like Breast Cancer
Potential for Added Medical Benefits Uncovered for Widely Used Breast Cancer Drug
Prognostic Value of Baseline HRQOL for Survival for 11 Types of Cancer Pointed Out by New Study
Research Suggests That Combination of Plant Nutrients Kills Breast Cancer Cells
Researchers Discover a New Driver of Breast Cancer
Scientists Find Potential Cause for Deadly Breast Cancer Relapse
Study Identifies New Trigger for Breast Cancer Metastasis
Two New Studies Evaluate the Growing Use of Breast MRI
Women Who Are Prescribed Combination Hormone Replacement Therapy Should Use Caution When Taking Apigenin Supplements
Young Breast Cancer Patients with Poorer Financial Status May Experience Delays in Seeking Care

Two New Studies Evaluate the Growing Use of Breast MRI

The overall use of breast magnetic resonance imaging has increased, with the procedure most commonly used for diagnostic evaluations and screenings, according to two new studies published in JAMA Internal Medicine.

However, while breast MRI is being used increasingly, its sensitivity leads to higher false-positive rates and it is also more expensive. Guidelines from the American Cancer Society (ACS) indicate that breast MRI should be used to screen asymptomatic women at high-risk for breast cancer if they are known carriers of the BRCA gene mutation; first-degree relatives of a known BRCA gene mutation carrier who are themselves untested; or a women with more than a 20 percent lifetime risk of breast cancer, according to the study background.

In the first study, Karen J. Wernli, Ph.D., of the Group Health Research Institute, Seattle, and colleagues examined the patterns of breast MRI in U.S. community practice from 2005 through 2009 with data collected from five national Breast Cancer Surveillance Consortium registries.

Study results show the overall rate of breast MRI nearly tripled from 4.2 to 11.5 examinations per 1,000 women from 2005 through 2009. The procedure was most commonly used for diagnostic evaluation (40.3 percent), followed by screening (31.7 percent). Women who underwent screening breast MRI were more likely to be younger than 50 years old, white, nulliparous (never had a baby), have a personal history of breast cancer, a family history of breast cancer and extremely dense breast tissue.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon